振德医疗: 振德医疗股东会议事规则

General Provisions - The rules are established to regulate the behavior of Zhengde Medical Supplies Co., Ltd., improve corporate governance, and ensure shareholders can exercise their rights according to the law [1][2]. Shareholder Meeting Regulations - The company must strictly follow legal and regulatory requirements when convening shareholder meetings, ensuring that all shareholders can exercise their rights [2][3]. - Shareholder meetings are categorized into annual and extraordinary meetings, with annual meetings held within six months after the end of the previous fiscal year [3][4]. Convening Shareholder Meetings - The board of directors is responsible for convening shareholder meetings within the stipulated timeframe [3][4]. - Independent directors can propose extraordinary meetings, and the board must respond within ten days [3][4][5]. Proposals and Notifications - Proposals must fall within the scope of the shareholder meeting's authority and be clearly defined [6][7]. - Shareholders holding 1% or more of shares can submit temporary proposals, which must be announced prior to the meeting [6][7]. Meeting Procedures - Shareholder meetings must be held at the company's registered location and can utilize online methods for convenience [8][9]. - All shareholders or their proxies have the right to attend the meeting, and the voting rights are based on the number of shares held [9][10]. Voting and Resolutions - Shareholders must abstain from voting on matters where they have a conflict of interest, and the voting results must be disclosed [11][12]. - The company must announce the resolutions of the shareholder meeting promptly, detailing the voting results and any decisions made [17][18]. Record Keeping - Meeting records must include details such as time, location, attendees, and voting results, and must be preserved for at least ten years [18][19]. Amendments and Effectiveness - The rules can be amended by the board of directors based on relevant laws and regulations, and they take effect upon approval by the shareholder meeting [20].